首页> 外国专利> PHARMACEUTICAL COMPOSITION FOR PROPHYLAXIS, TREATMENT OR INHIBITION OF DEVELOPMENT OF SIMPLE RETINOPATHY AND PREPROLIFERATING RETINOPATHY

PHARMACEUTICAL COMPOSITION FOR PROPHYLAXIS, TREATMENT OR INHIBITION OF DEVELOPMENT OF SIMPLE RETINOPATHY AND PREPROLIFERATING RETINOPATHY

机译:单纯性视网膜病变和增殖性视网膜病变的药物组成,治疗或抑制

摘要

FIELD: organic chemistry, medicine, chemical-pharmaceutical industry, pharmacy.;SUBSTANCE: invention relates to a pharmaceutical composition comprising 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazol-7-carboxylic acid or 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazol-7-carboxylate used for prophylaxis, treatment or inhibition of development of simple retinopathy or preproliferative retinopathy. Also, invention relates to a method for prophylaxis, treatment of inhibition of development of simple retinopathy or preproliferative retinopathy and to applying 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazol-7-carboxylic acid or 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazol-7-carboxylate. Pharmaceutical composition elicits the enhanced effectiveness and bioavailability.;EFFECT: valuable medicinal properties of composition.;4 cl, 1 tbl, 3 ex
机译:药物组合物技术领域本发明涉及包含2-乙氧基-1-[[[2'-(1H-四唑-5-基)联苯-4-基]的药物组合物。甲基]苯并咪唑-7-羧酸或2-乙氧基-1-[[[2'-(1H-四唑-5-基)联苯-4-基]甲基]苯并咪唑-7-羧酸盐用于预防,治疗或抑制单纯性视网膜病变或增生性视网膜病变的发展。另外,本发明涉及预防,抑制单纯性视网膜病或增生前性视网膜病发展的方法,并涉及使用2-乙氧基-1-[[2'-(1H-四唑-5-基)联苯-4-基]甲基]苯并咪唑-7-羧酸或2-乙氧基-1-[[[2'-(1H-四唑-5-基)联苯-4-基]甲基]苯并咪唑-7-羧酸酯。药物组合物引起增强的有效性和生物利用度。效果:该组合物的有价值的药物特性。4 cl,1 tbl,3 ex

著录项

  • 公开/公告号RU2239454C2

    专利类型

  • 公开/公告日2004-11-10

    原文格式PDF

  • 申请/专利权人

    申请/专利号RU20010132073

  • 申请日2000-04-27

  • 分类号A61K45/00;A61K31/4184;A61P27/02;A61P9/12;

  • 国家 RU

  • 入库时间 2022-08-21 22:44:50

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号